UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307C902. A total of 3 filers reported holding UNITED THERAPEUTICS CORP DEL in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $618,100 | -48.3% | 2,800 | -34.9% | 0.00% | -33.3% |
| Q4 2022 | $1,195,787 | -77.4% | 4,300 | -83.0% | 0.00% | -70.0% |
| Q3 2022 | $5,297,000 | +507.5% | 25,300 | +583.8% | 0.01% | +900.0% |
| Q2 2022 | $872,000 | -50.2% | 3,700 | -54.3% | 0.00% | 0.0% |
| Q4 2021 | $1,750,000 | +39.4% | 8,100 | +19.1% | 0.00% | 0.0% |
| Q3 2021 | $1,255,000 | -43.1% | 6,800 | -44.7% | 0.00% | -66.7% |
| Q2 2021 | $2,207,000 | +43.4% | 12,300 | +33.7% | 0.00% | +50.0% |
| Q1 2021 | $1,539,000 | +271.7% | 9,200 | +124.4% | 0.00% | +100.0% |
| Q3 2020 | $414,000 | +101.0% | 4,100 | +141.2% | 0.00% | 0.0% |
| Q2 2020 | $206,000 | -54.7% | 1,700 | -64.6% | 0.00% | -75.0% |
| Q1 2020 | $455,000 | +475.9% | 4,800 | +433.3% | 0.00% | +300.0% |
| Q4 2019 | $79,000 | -71.9% | 900 | -75.0% | 0.00% | -66.7% |
| Q2 2019 | $281,000 | -31.6% | 3,600 | +2.9% | 0.00% | -40.0% |
| Q1 2019 | $411,000 | +114.1% | 3,500 | +133.3% | 0.01% | +150.0% |
| Q3 2018 | $192,000 | -70.2% | 1,500 | -73.7% | 0.00% | -66.7% |
| Q2 2018 | $645,000 | 0.0% | 5,700 | +3.6% | 0.01% | 0.0% |
| Q3 2017 | $645,000 | – | 5,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 25,000 | $3,216,000 | 1.72% |
| SABBY MANAGEMENT, LLC | 870 | $11,193,000 | 0.43% |
| PEAK6 Group LLC | 41,800 | $5,378,000 | 0.04% |
| Citadel Advisors | 59,900 | $7,706,000 | 0.01% |